Genetic differences in interleukin-1 βpolymorphisms among four Asian populations: An analysis of the Asian paradox between H.pylori infection and gastric cancer incidence

Journal of Experimental and Clinical Cancer Research

Volumn 22, Issue 1, 2003, Pages 47-55

  Matsukura, Norio ^a   Yamada, S ^a,b   Kato, S ^a   Tomtitchong, P ^c   Tajiri, T ^a   Miki, M ^a   Matsuhisa, T ^d   Yamada, N ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Faculty of Medicine Chiang Mai University   (Thailand)

^c THAMMASAT UNIVERSITY   (Thailand)

^d NIPPON MEDICAL SCHOOL TAMA NAGAYAMA HOSPITAL   (Japan)

Author keywords

Ethnic group; Gastric cancer; Genetic polymorphism; Helicobacter pylori; Interleukin 1

Indexed keywords

INTERLEUKIN 1BETA; PEPSINOGEN I; PEPSINOGEN II;

ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; ATROPHY; BACTERIAL COLONIZATION; CANCER INCIDENCE; CANCER RISK; CHINESE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOSCOPIC BIOPSY; FEMALE; GASTRITIS; GENE FREQUENCY; GENETIC DIFFERENCE; GENETIC POLYMORPHISM; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; INTESTINE METAPLASIA; JAPAN; MAJOR CLINICAL STUDY; MALE; MICROBIAL ACTIVITY; PRIORITY JOURNAL; STOMACH ANTRUM; STOMACH CANCER; THAILAND; VIET NAM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BIOPSY; CHINA; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; INTERLEUKIN-1; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; STOMACH NEOPLASMS; THAILAND; VIETNAM;

EID: 0037351785     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ferlay J., Parkin D.M., Pisani P.: Globocan 1: Cancer Incidence and Mortality Worldwide. IARC/WHO, IARC Press, Lyon, 1998.
2. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori. IARC Monographs on the Evaluation of Carcinogenic Risks to Human 61, IARC, Lyon, 1994: 177-241.
3. Uemura N., Okamoto S., Yamamoto S., et al.: Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345: 784-789, 2001.
4. Sugiyama A., Maruta F., Ikeno T., et al.: Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbils. Cancer Res. 58: 2067-2069, 1998.
5. Shimizu N., Ikehara Y., Inada K., et al.: Eradication diminishes enhancing effects of Helicobacter pylori infection on glandular stomach carcinogenesis in Mongolian gerbils. Cancer Res. 60: 1512-1514, 2000.
6. Hu P.J., Li Y.Y., Zhou M.H. et al.: Helicobacter pylori associated with a high prevalence of duodenal ulcer disease and a low prevalence of gastric cancer in a developing nation. Gut 36: 198-202, 1995.
7. Perez-Perez G., Taylor D.N., Bodhidatta L., et al.: Seroprevalence of Helicobacter pylori infections in Thailand. J. Infec. Dis. 161: 1237-1241, 1990.
8. Noach L.A. Bosma N.B.?Jansen J., et al.: Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand. J. Gastroenterol. 29: 425-429, 1994.
9. Beales I., Calam J.: Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 42: 227-234, 1998.
10. El-Omar E.M., Carrington M., Chow W.-H., et al: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404: 398-376, 2000.
11. Yamada N., Matsukura N., Matsuhisa T.: Triple site biopsy under endoscopy. Nippon Rinsyo 59: 252-257, 2001 (In Japanese with English abstract).
12. Dixon M.F., Genta R.M., Yardely J.H., Correa P.: Classification and grading of gastritis. The Updated Sydney System. Am. J. Surg. Pathol. 20: 1161-1181, 1996.
13. Yamada S., Onda M., Kato S., et al.: Genetic differences in CYP2C19 single nucleotide polymorphisms among four Asian populations. J. Gastroenterol. 36: 669-672, 2001.
14. Kato S., Onda M., Yamada S., et al.: Association of the interleukin-1bgenetic polymorphism and gastric cancer risk in Japanese. J. Gastroenterol. 36: 696-699, 2001.
15. Miki K., Ichinose M., Kawamura N., et al: The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn. J. Cancer Res. 80: 111-114, 1989.
16. Kinoshita Y., Kawanami C., Kishi K., Nakata H., Seino Y., Chiba T.: Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese. Gut 41: 452-458, 1997.
17. Kang J.Y., Wee A., Math M.V. et al.: Helicobacterpylori and gastritis in patients with peptic ulcer and non-ulcer dyspepsia: ethnic differences in Singapore. Gut 31: 850-853, 1990.
18. Goh K.L.: Epidemiology of Helicobacter pylori infection, peptic ulcer and gastric cancer: Experience in a Multiracial South East Asian Country. Helicobacter Res. 4: 34-40, 2000.
19. Correa P.: Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res. 52: 6735-6740, 1992.
20. Peek R.M. Jr.: Helicobacter pylori strain-specific activation of signal transduction cascades related to gastric inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 280: G525-G530, 2001.
21. Odenbreit S., Gebert B., Puls J., et al.: Interaction of Helicobacterpylori with professional phagocytes: role of the cag pathogenicity island and translocation, phosphorylation and processing of CagA. Cell Microbiol. 3: 21-31, 2001.
22. Correa P., Cuello C., Duque E.: Carcinoma and intestinal metaplasia of the stomach in Colombian migrants. J. Natl. Cancer Inst. 44: 297-306, 1970.
23. Stemmermann G.N., Ishidate T., Samloff I.M., et al.: Intestinal metaplasia of the stomach in Hawaii and Japan. A study of its relation to serum pepsinogen I, gastrin, and parietal cell antibodies. Am. J. Dig. Dis. 23: 815-820, 1978.
24. Matsukura N., Suzuki K., Kawachi T., et al: Distribution of marker enzymes and mucin in intestinal metaplasia in human stomach and relation of complete and incomplete types of intestinal metaplasia to minute gastric carcinoma. J. Natl. Cancer Inst. 64: 231-240, 1980.
25. Blaser M.J.: Linking Helicobacter pylori to gastric cancer. Nature Med. 6: 376-377, 2000.
26. Sato S., Fukuyama S., Suzuki T., et al.: The relationship between gastric cancer mortality and salted food intake in several places in Japan. Bull. Inst. Public Health 8: 187-198, 1959.
27. Hamajima N., Matsuo K., Saito T., et al.: Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection. Jpn. J. Cancer Res. 92: 383-389, 2001.
28. Matsukura N., Onda M., Kato S., et al.: Cytotoxin genes of Helicobacterpylori in chronic gastritis, gastroduodenal ulcer and gastric cancer: an age and gender matched case-control study. Jpn. J. Cancer Res. 88: 532-536, 1997.
29. Pongchairerks P., Matsukura N., Bhumisirikul P., et al.: The occurrence of Helicobacter pylori and its virulence factor in Thai people with gastritis, peptic ulcers and gastric cancer: preliminary results. Ramathibodi Med. J. 20: 103-107, 1997.
30. Hansson L-E., Lyrẽn O., Hsing AW., Bergstrom R., Josefsson S., Chow W.-H., Fraumeni J.F., Adami H.-O.: The risk of stomach cancer in patients with gastric or duodenal ulcer diseases. N. Engl. J. Med. 335: 242-249, 1996.
31. Matsuhisa T., Yamada N., Kato S., Matsukura N.: Helicobacter pylori infection, mucosal atrophy and intestinal metaplasia in Asian populations: A comparative study in age-, gender-, and endoscopic diagnosis-matched study. Helicobacter 8:2003, in press.
32. Furuta T., Shirai N., Takashima M., Xiao F., Sugimura H.: Effect of genotypic difference in interleukin-1 beta on gastric acid secretion in Japanese patients infected with Helicobacter pylori. Am. J. Med. 112: 141-143, 2002.
33. Banerjee S., Hawksby C., Miller S., Dahill S., Beattie A.D., McColl K.E.L.: Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut 35: 317-322, 1994.